Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Shire Pharmaceuticals Ireland Limited, against the decision of the State Institute for Drug Control from 24. 3. 2020, under the no. SUKLS328237/2019 - The appeal is dismissed and the decision under appeal is upheld.

Source of information: MZ ČR

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).

 

Více na: EN SUKL - List of reimbursed medicinal products

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant AstraZeneca AB, against the decision of the State Institute for Drug Control from 27. 12. 2019, under the no. SUKLS166510/2017 - The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only) 

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Glenmark Pharmaceuticals s.r.o., against the decision of the State Institute for Drug Control from 8. 9. 2017, under the no. SUKLS53138/2017 - The decision under appeal is reversed and the proceedings are terminated.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Sandoz GmbH, against the decision of the State Institute for Drug Control from 7. 5. 2019, under the no. SUKLS344150/2018 - The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Všeobecná zdravotní pojišťovna České republiky against the decision of the State Institute for Drug Control from 1. 9. 2017, under the no. SUKLS142481/2017 - The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Amgen Europe B.V. against the decision of the State Institute for Drug Control from 14. 4. 2020, under the no. SUKLS284431/2019 - The decision under appeal is reversed and the proceedings are terminated.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Svaz zdravotních pojišťoven against the decision of the State Institute for Drug Control from 22. 9. 2017, under the no. SUKLS64032/2016 - the operative part 2 and 4 of the decision under appeal is dismissed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz (czech version only)